Commercially-viable Complementary or Companion Diagnostic Tests
Serametrix can generate commercially-viable complementary or companion diagnostic tests from our custom CLIA assays. A rather new concept, a complementary diagnostic is a test that produces meaningful clinical evidence that aids in risk-benefit decision-making regarding the use of a therapeutic treatment. This clinical testing approach is now hardwired into biomarker development. Biomakers, like MDSC for example, have evolved from an exploratory research assay to a CLIA clinical tool for patient selection. In partnering with Infinity Pharmaceuticals, the Serametrix CLIA MDSC assay is being used to assess MDSC levels for patient stratification in their clinical trial.
To discuss ideas for your study or request a quote, click here.